Effects of a prolonged administration of valepotriates in rats on the mothers and their offspring
Department of Psychobiology, Escola Paulista de Medicina, São Paulo, Brazil. Journal of Ethnopharmacology
(Impact Factor: 3).
02/1994; 41(1-2):39-44. DOI: 10.1016/0378-8741(94)90055-8
Valeriana officinalis L. (Valerianaceae) is widely known to be associated with sedative properties. The effects of a valepotriates mixtures on mothers and progeny were evaluated in rats. A 30-day administration of valepotriates did not change the average length of estral cycle, nor the number of estrous phases during this period. Also, there were no changes on the fertility index. Fetotoxicity and external examination studies did not show differences, although internal examination revealed an increase in number of retarded ossification after the highest doses employed--12 and 24 mg/kg. No changes were detected in the development of the offspring after treatment during pregnancy. As for temperature, valepotriates caused a hypothermizant effect after administration by the intraperitoneal route but not after oral administration. Generally, the valepotriates employed induced some alterations after administration by the intraperitoneal route, but doses given orally were innocuous to pregnant rats and their offspring.
Available from: sciencedirect.com
- "The citotoxic effects of valepotriates in vitro were already demonstrated (Bounthanh et al., 1983; Lin et al., 2009). However, in vivo experiments have not demonstrated toxicity in rats orally administered with valepotriates (Tufik et al., 1994). In summary, literature data regarding the pharmacological activity of valepotriates are not very extensive and present some dissonant results. "
[Show abstract] [Hide abstract]
ABSTRACT: The antidepressant-like effect of a supercritical CO2 (SCCO2) Valeriana glechomifolia extract enriched in valepotriates was investigated in a mice tail suspension test (TST) and forced swimming test (FST). The SCCO2 extract decreased mice immobility in the FST (0.5-20 mg/kg p.o.) and elicited a biphasic dose-response relationship in the TST (1-20 mg/kg p.o.) with no alterations in locomotor activity and motor coordination (assessed in the open-field and rota-rod tests, respectively). The anti-immobility effect of the SCCO2 extract (5 mg/kg, p.o.) was prevented by mice pre-treatment with yohimbine (1 mg/kg, i.p., an α2 adrenoceptor antagonist), SCH 23390 (15 μg/kg, s.c., D1 dopamine receptor antagonist) and sulpiride (50 mg/kg, i.p., D2 dopamine receptor antagonist). However, mice pre-treatments with prazosin (1 mg/kg, i.p., α1 adrenoceptor antagonist) and p-chlorophenilalanine methyl ester (4×100 mg/kg/day, i.p., a serotonin synthesis inhibitor) were not able to block the anti-immobility effect of the SCCO2 extract. Administration (p.o.) of the SCCO2 extract (0.25 mg/kg) and imipramine (10 mg/kg), desipramine (5 mg/kg) and bupropion (3 mg/kg) at sub-effective doses significantly reduced mice immobility time in the FST. These data provide the first evidence of the antidepressant-like activity of V. glechomifolia valepotriates, which is due to an interaction with dopaminergic and noradrenergic neurotransmission.
Progress in Neuro-Psychopharmacology and Biological Psychiatry 08/2011; 36(1):101-9. DOI:10.1016/j.pnpbp.2011.08.015 · 3.69 Impact Factor
Available from: João Ricardo Gonçalves de Oliveira
- "The hatches were standardized by the number of animals per hatch: only four animals per hatch were left for subsequent observation. These animals consisted of 2 male and 2 female (Tufik et al., 1994). "
Journal of medicinal plant research 12/2007; 1(5):109-112. · 0.88 Impact Factor
Available from: Alexander George Panossian
- "Likewise, ginseng extract has been shown to be completely non-toxic in acute and chronic toxicity tests with five animal models (Soldati, 1984; Bradley, 1992; Sonnenborn and Ha¨nsel, 1992; World Health Organisation, 1999) and is known to improve sperm production (Owen, 1981; World Health Organisation, 1999). In contrast, Tufik et al. (1994) reported a negative effect of valerian on reproduction, whilst Chan et al. (2003) observed direct teratogenic effects on rat embryos by a ginsenoside administered in amounts equivalent to normal human intake. "
[Show abstract] [Hide abstract]
ABSTRACT: The safety of different doses of Kan Jang--a fixed combination of Andrographis paniculata special extract (SHA-10) and Acanthopanax senticosus--compared to two extensively used medicinal plants, Valeriana officinalis and Panax ginseng in the form of standardized extracts, has been examined. A phase I clinical study was designed to evaluate the effect on semen quality of healthy males in terms of spermatogenesis and quality of semen. The results of the study revealed no significant negative effect of Kan Jang on male semen quality and fertility, but rather a positive trend with respect to the number of spermatozoids in the whole ejaculate, the percentage of active (normokinetic) forms of spermatozoids, and fertility indexes, together with a decrease in the percentage of inactive (diskinetic) forms of spermatozoids. In the group receiving ginseng, no significant negative effects on the fertility parameters were revealed and there was a clear decrease in the percentage of diskinetic forms of spermatozoids. Subjects receiving valerian showed a temporary increase in the percentage of normokinetic spermatozoids and a decrease in diskinetic forms, but these changes had no effect on fertility indices. The results indicate that Kan Jang, ginseng and valerian are safe with respect to effects on human male sterility when administered at dose levels corresponding to approximately 3 times the human daily dose.
Phytomedicine 07/2005; 12(6-7):403-9. DOI:10.1016/j.phymed.2004.10.004 · 3.13 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.